RMA EXAM
+t
Exam Solution
+t
Certified Specialty Pharmacist (CSP) Exam 2026 A+ GRA
+t +t +t +t +t +t +t
DE ASSURED COMPLETE SOLUTIONS AND VERIFIED AN
+t +t +t +t +t +t
SWERS (59D56) +t
QUESTION 1 +t
CD4/6 that can be used as monotherpy
+t +t +t +t +t +t
ANSWER
Verzenio (abemaciclib)+t
QUESTION 2 +t
ibrance (palbociclib) tablets with or without food?
+t +t +t +t +t +t
ANSWER
either
QUESTION 3 +t
ibrance (palbociclib) capsules with or without food?
+t +t +t +t +t +t
ANSWER
with
QUESTION 4 +t
main ADE of Ibrance (palbociclib)
+t +t +t +t
ANSWER
myelosupression
,QUESTION 5 +t
main ades of Kisquali (ribociclib)
+t +t +t +t
ANSWER
myelosupression QTc prolongation +t +t
QUESTION 6 +t
verzenio (abemaciclib) main ADE
+t +t +t
ANSWER
diarrhea
QUESTION 7 +t
sutent (sunitinib) advance renal cancer dose
+t +t +t +t +t
ANSWER
50mg PO once daily for 4 weeks on, and then 2 weeks off until progression
+t +t +t +t +t +t +t +t +t +t +t +t +t +t
QUESTION 8 +t
sutent (sunitinib) Adjuvant treatment of adult patients at high risk of recurrent RCC foll
+t +t +t +t +t +t +t +t +t +t +t +t +t
owing nephrectomy dose
+t +t
ANSWER
50mg PO once daily for 4 weeks on, and then 2 weeks off for 9 cycles only
+t +t +t +t +t +t +t +t +t +t +t +t +t +t +t +t
QUESTION 9 +t
Votrient (pazopanib) side effects
+t +t +t
ANSWER
pain (tumor, GI, musculoskeletal) dyspnea
+t +t +t +t
QUESTION 10 +t
votrient (pazopanib) BBW
+t +t
ANSWER
hepatotoxicity
,QUESTION 11 +t
Stivarga (regorafenib) BBW +t +t
ANSWER
hepatotoxicity
QUESTION 12 +t
sutent (sunitinib) BBW
+t +t
ANSWER
hepatotoxicity
QUESTION 13 +t
Bosulif (bosutinib) indication
+t +t
ANSWER
Chronic myeloid leukemia, Philadelphia chromosome positive
+t +t +t +t +t
QUESTION 14 +t
Bosulif (bosutinib) with or without food
+t +t +t +t +t
ANSWER
with
QUESTION 15 +t
Bosulif (bosutinib) with grapefruit juice?
+t +t +t +t
ANSWER
no
QUESTION 16 +t
Bosulif (bosutinib) and acid supressing agents
+t +t +t +t +t
ANSWER
avoid PPIs Separate administration of antacids or H2 antagonists from bosutinib by at least 2 hours
+t +t +t +t +t +t +t +t +t +t +t +t +t +t +t
, QUESTION 17 +t
Gleevec (imatinib) ADE+t +t
ANSWER
heart failure (SOB)
+t +t
QUESTION 18 +t
Gleevec (imatinib) and grapefruit?
+t +t +t
ANSWER
no
QUESTION 19 +t
Iclusig (ponatinib) mutation
+t +t
ANSWER
T315I-positive
QUESTION 20 +t
Iclusig (ponatinib) BBW
+t +t
ANSWER
Aterial thrombosis Hepatotoxicity
+t +t
QUESTION 21 +t
Iclusig (ponatinib) and grapefruit juice
+t +t +t +t
ANSWER
no
QUESTION 22 +t
Sprycel (dasatinib) mutation
+t +t
ANSWER
Ph+
+t
Exam Solution
+t
Certified Specialty Pharmacist (CSP) Exam 2026 A+ GRA
+t +t +t +t +t +t +t
DE ASSURED COMPLETE SOLUTIONS AND VERIFIED AN
+t +t +t +t +t +t
SWERS (59D56) +t
QUESTION 1 +t
CD4/6 that can be used as monotherpy
+t +t +t +t +t +t
ANSWER
Verzenio (abemaciclib)+t
QUESTION 2 +t
ibrance (palbociclib) tablets with or without food?
+t +t +t +t +t +t
ANSWER
either
QUESTION 3 +t
ibrance (palbociclib) capsules with or without food?
+t +t +t +t +t +t
ANSWER
with
QUESTION 4 +t
main ADE of Ibrance (palbociclib)
+t +t +t +t
ANSWER
myelosupression
,QUESTION 5 +t
main ades of Kisquali (ribociclib)
+t +t +t +t
ANSWER
myelosupression QTc prolongation +t +t
QUESTION 6 +t
verzenio (abemaciclib) main ADE
+t +t +t
ANSWER
diarrhea
QUESTION 7 +t
sutent (sunitinib) advance renal cancer dose
+t +t +t +t +t
ANSWER
50mg PO once daily for 4 weeks on, and then 2 weeks off until progression
+t +t +t +t +t +t +t +t +t +t +t +t +t +t
QUESTION 8 +t
sutent (sunitinib) Adjuvant treatment of adult patients at high risk of recurrent RCC foll
+t +t +t +t +t +t +t +t +t +t +t +t +t
owing nephrectomy dose
+t +t
ANSWER
50mg PO once daily for 4 weeks on, and then 2 weeks off for 9 cycles only
+t +t +t +t +t +t +t +t +t +t +t +t +t +t +t +t
QUESTION 9 +t
Votrient (pazopanib) side effects
+t +t +t
ANSWER
pain (tumor, GI, musculoskeletal) dyspnea
+t +t +t +t
QUESTION 10 +t
votrient (pazopanib) BBW
+t +t
ANSWER
hepatotoxicity
,QUESTION 11 +t
Stivarga (regorafenib) BBW +t +t
ANSWER
hepatotoxicity
QUESTION 12 +t
sutent (sunitinib) BBW
+t +t
ANSWER
hepatotoxicity
QUESTION 13 +t
Bosulif (bosutinib) indication
+t +t
ANSWER
Chronic myeloid leukemia, Philadelphia chromosome positive
+t +t +t +t +t
QUESTION 14 +t
Bosulif (bosutinib) with or without food
+t +t +t +t +t
ANSWER
with
QUESTION 15 +t
Bosulif (bosutinib) with grapefruit juice?
+t +t +t +t
ANSWER
no
QUESTION 16 +t
Bosulif (bosutinib) and acid supressing agents
+t +t +t +t +t
ANSWER
avoid PPIs Separate administration of antacids or H2 antagonists from bosutinib by at least 2 hours
+t +t +t +t +t +t +t +t +t +t +t +t +t +t +t
, QUESTION 17 +t
Gleevec (imatinib) ADE+t +t
ANSWER
heart failure (SOB)
+t +t
QUESTION 18 +t
Gleevec (imatinib) and grapefruit?
+t +t +t
ANSWER
no
QUESTION 19 +t
Iclusig (ponatinib) mutation
+t +t
ANSWER
T315I-positive
QUESTION 20 +t
Iclusig (ponatinib) BBW
+t +t
ANSWER
Aterial thrombosis Hepatotoxicity
+t +t
QUESTION 21 +t
Iclusig (ponatinib) and grapefruit juice
+t +t +t +t
ANSWER
no
QUESTION 22 +t
Sprycel (dasatinib) mutation
+t +t
ANSWER
Ph+